Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fulcrum Therapeutics Inc (NQ: FULC )

6.750 +0.050 (+0.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 395,810
Open 6.670
Bid (Size) 6.600 (5)
Ask (Size) 7.880 (7)
Prev. Close 6.700
Today's Range 6.520 - 7.205
52wk Range 3.210 - 24.79
Shares Outstanding 52,051,405
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap Conference
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire

Performance

YTD
-62.12%
-62.12%
1 Month
+10.66%
+10.66%
3 Month
-9.64%
-9.64%
6 Month
-10.36%
-10.36%
1 Year
-51.89%
-51.89%

More News

Read More
Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire
Recap: Fulcrum Therapeutics Q2 Earnings
Via Benzinga
4 Analysts Have This to Say About Fulcrum Therapeutics
Via Benzinga
Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire
Fulcrum Therapeutics Earnings Preview
Via Benzinga
Fulcrum Therapeutics® to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Tuesday, November 8, 2022 at 8:00 a.m. ET
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire
Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Fulcrum Therapeutics to Present New Data from the Open Label Extension of Phase 2 ReDUX4 Study at the World Muscle Society (WMS) Congress in Halifax, Canada
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Fulcrum Therapeutics, Inc.
Via Globe NewsWire
U.S. Stock Futures Edge Lower Ahead Of Walmart, Home Depot Earnings
Via Benzinga
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Fulcrum Therapeutics Earnings Preview
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble
Via Benzinga
91 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump
Via Benzinga
44 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.